Gibson Christopher sold RXRX
March 23, 2026 · Form 4 insider transaction
Gibson Christopher sold 40,000 shares of Recursion Pharmaceuticals, Inc. at $3.25 per share, a transaction worth $130.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
40,000
Price
$3.25
Total value
$130.0K
InsiderGibson Christopher
Role—
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateMarch 23, 2026
Filing dateMarch 25, 2026
Shares owned after906,556
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 12, 2025.